NOHE SEBHATU: Open Payments
NPI 1093175226 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 29 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,360 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $105 |
| GENZYME CORPORATION | 2 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| UCB, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| LEO Pharma Inc. | 2 | $48 |
| Surgenex LLC | 1 | $43 |
| Amgen Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: Opzelura, DUPIXENT, Bimzelx, CIBINQO, Sotyktu, COSENTYX, ADBRY, SurGraft.
Industry payments across AZ — which companies pay providers there.
